Shane Thomas Gleason sold $99k of NSPR
Chief Commercial Officer at InspireMD, Inc.. 61,194 shares at an average of $1.62, traded Jan 15, 2026, filed Feb 2, 2026.
Score components
- +15RoleOfficer
- +10Trade size$99k at market
- 0Share of holdings soldSold 5.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m -28.2%, 6m -58.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-004773, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | SOpen-market sale Common Stock | -2,909 | $1.58 | $4,593 | 1,197,462 | Feb 2, 2026 |
| Jan 16, 2026 | SOpen-market sale Common Stock | -2,250 | $1.61 | $3,627 | 1,195,212 | Feb 2, 2026 |
| Jan 20, 2026 | SOpen-market sale Common Stock | -2,955 | $1.59 | $4,710 | 1,192,257 | Feb 2, 2026 |
| Jan 21, 2026 | SOpen-market sale Common Stock | -17,593 | $1.62 | $29k | 1,174,664 | Feb 2, 2026 |
| Jan 22, 2026 | SOpen-market sale Common Stock | -8,411 | $1.57 | $13k | 1,166,253 | Feb 2, 2026 |
| Jan 27, 2026 | SOpen-market sale Common Stock | -4,781 | $1.66 | $7,956 | 1,161,472 | Feb 2, 2026 |
| Jan 28, 2026 | SOpen-market sale Common Stock | -12,395 | $1.65 | $20k | 1,149,077 | Feb 2, 2026 |
| Jan 29, 2026 | SOpen-market sale Common Stock | -5,000 | $1.65 | $8,250 | 1,144,077 | Feb 2, 2026 |
| Jan 30, 2026 | SOpen-market sale Common Stock | -2,900 | $1.63 | $4,730 | 1,141,177 | Feb 2, 2026 |
| Feb 2, 2026 | SOpen-market sale Common Stock | -2,000 | $1.60 | $3,208 | 1,139,177 | Feb 2, 2026 |
Related signals
Other insiders at InspireMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | NSPRbuy InspireMD, Inc. | Paul Stuka director | $18k 20,000 shares | +3% | |
| 27Weak | NSPRsell InspireMD, Inc. | Shane Thomas Gleason Chief Commercial Officer | $190k 85,295 shares | -7% | |
| 48Moderate | InspireMD, Inc. | Paul Stuka director | $17k 15,000 shares | +2% | |
| 58Moderate | InspireMD, Inc. | Marvin Slosman CEO and President | $25k 21,000 shares | +1% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 61Notable | InspireMD, Inc. | Gary S Roubin director | $106k 90,000 shares | +12% | |
| 43Moderate | InspireMD, Inc. | Paul Stuka director | $9,034 7,895 shares | +2% | |
| 68Notable | InspireMD, Inc. | Scott R. Ward director | $103k 89,250 shares | +60% | |
| 23Weak | NSPRbuy InspireMD, Inc. | Paul Stuka director | $4,905 2,710 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.